Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28233244 | 0.89 | CYP1A2 (0.41) | SLC7A5OPRK1OPRM1OPRD1FOLH1 | |
| SCHEMBL7106924 | 0.88 | ITGB1 (0.34) | SLC7A5 | |
| SCHEMBL7299550 | 0.84 | PPARA (0.40) | — | |
| SCHEMBL7299078 | 0.81 | PPARD (0.39) | — | |
| SCHEMBL7424094 | 0.81 | ITGB3 (0.41) | — | |
| SCHEMBL7292750 | 0.80 | ITGB3 (0.42) | OPRK1OPRM1OPRD1 | |
| SCHEMBL7417141 | 0.78 | SLC7A5 (0.42) | SLC7A5OPRK1OPRM1OPRD1MIF | |
| SCHEMBL9308843 | 0.78 | ITGB3 (0.58) | — | |
| SCHEMBL27507556 | 0.77 | ATM (0.41) | MIF | |
| SCHEMBL8182265 | 0.77 | SRR (0.43) | CTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020252713-A1 | MODIFIED HYDROPHOBIC AUXILIARY MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | 浙江智达药业有限公司 | 2020-12-24 | — | — | WO | disclosed |